RBR-2fr526n
Completed
未知
Effects of cell therapy with mesenchymal stem cells from adipose tissue and platelet-rich plasma in the treatment of osteoartrite that was not responsive to drug treatment
niversidade Federal de Mato Grosso do Sul0 sitesNovember 16, 2021
ConditionsOsteoarthritis, Knee
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Osteoarthritis, Knee
- Sponsor
- niversidade Federal de Mato Grosso do Sul
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Volunteer individuals were included; diagnosed through physical assessment; be classified by imaging with osteoarthritis grade II to IV; who already had an indication for knee surgery; patients unresponsive to conservative treatment (physical and drug) commonly used in the Unified Health System (SUS) for at least 6 months.
Exclusion Criteria
- •Individuals with extreme deformities of the knee joint were excluded; who reported having hemophilia, anemia, gastrointestinal diseases, cancer, thyroid, liver, and previous nephrological disorders and HIV; patients who were chronically using immunosuppressive and anticoagulant drugs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Evaluation of Mesenchymal stem cell therapy effects on the cellular immune response in refractory rheumatoid arthritis patientsRheumatoid arthritis.Diseases of the musculoskeletal system and connective tissueIRCT2015102824760N1Research Chancellor, Mashhad University of Medical Sciences21
Active, not recruiting
Phase 1
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeModerate to severe SARS-Cov-2 related acute respiratory distress syndromeMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2020-002772-12-FRCHRU NANCY30
Recruiting
Phase 1
Evaluation the efficacy of stem cells condition medium on hair transplantation outcomeHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N18Skin and Stem cell Research Center of Tehran University of Medical Sciences30
Completed
Not Applicable
Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantatiorefractoty acute GVHD after stem cell transplantationJPRN-C000000423Jichi Medical University, Department of Medicine, Division of Hematology5
Terminated
Phase 2
Intra-articular mesenchymal stem cell injections following arthroscopic microfracture versus arthroscopic microfracture alone for knee cartilage defects: a pilot randomised controlled trialACTRN12614000812695Magellan Stem Cells40